Study on the levels of calcitonin gene-related peptide, somatostatin and inflammatory factors in patients with coronary artery  disease complicated with type 2 diabetes mellitus

Zhang, Chenyang; Ye, Lifang; Song, Yingxiang; Wang, Lihong

doi:10.21203/rs.3.rs-56283/v1

Cited by 3 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to relevant research, the patients with early diabetes are characterized by damp heat, marked weakness, weakness of glucose tolerance, treatment of dampness and spleen, clearing away heat and dampness. [17,18] According to relevant studies [19] , the effect of Simiao particles on early type 2 diabetic patients is significant, which can effectively reduce the levels of FBG and PBG, FINS and HbAlc. HOMA-IR, IAI, BMI and other indicators of the patient were significantly improved, without adverse reactions.…”

Section: Drying Dampness and Strengthening Spleenmentioning

confidence: 99%

Progress Research into the Treatment of Newly Diagnosed Type 2 Diabetes with Traditional Chinese Medicine

2022

FMSR

View full text Add to dashboard Cite

For newly diagnosed type 2 diabetic patients, the treatment of the illness is very important, which is related to the patient's condition control. Scientific and effective treatment can delay the progression of the patient's illness, reduce the incidence of complications, and improve the quality of life of the patients. Traditional Chinese medicine is a hot research topic in recent years. It is effective in treating type 2 diabetes. Traditional Chinese medicine believes that diabetes is highly similar to the symptoms of diabetes, such as thirst elimination and spleen bleeding in the classics of traditional Chinese medicine. In terms of treatment, it pays attention to the mechanism of drying dampness, invigorating spleen, replenishing qi and nourishing yin and replenishing spleen and kidney. This paper is about the research progress of using traditional Chinese medicine in the treatment of newly diagnosed type 2 diabetes.

show abstract

Section: Drying Dampness and Strengthening Spleenmentioning

confidence: 99%

Progress Research into the Treatment of Newly Diagnosed Type 2 Diabetes with Traditional Chinese Medicine

2022

FMSR

View full text Add to dashboard Cite

show abstract

“…According to the theory of traditional Chinese medicine (TCM), acupuncture can regulate qi and blood and have a direct impact on bioavailability of substances of the body [18]. In the past 20 years, several randomized controlled trials (RCTs) have been conducted on the effectiveness of acupuncture on diabetes mellitus and its complications [19][20][21]. It has been demonstrated that acupuncture may improve insulin sensitivity [18,22] and c-peptide levels through effective treatment against metabolic disturbances such as hyperglycaemia [21,23,24], overweight [24,25], inflammation [26], while improving lipid metabolism [27].…”

Section: Introductionmentioning

confidence: 99%

Effectiveness of acupuncture as adjunctive therapy in type 2 diabetic: Study protocol for a randomized controlled trial

Cheok,

Mohd Shariff,

Chan

et al. 2023

PLoS ONE

View full text Add to dashboard Cite

Introduction The incidence of type 2 diabetes mellitus is increasing worldwide. The literature suggests that acupuncture is a possible complementary therapy for type 2 diabetes mellitus. This study aims to determine the effectiveness of acupuncture as an adjunctive therapy on homeostasis model assessment-insulin resistance (HOMA-IR), and health-related quality of life (HRQoL) in patients with type 2 diabetes mellitus. Materials and methods This randomized, double-blind, placebo controlled, and parallel design trial will be carried out in a public university teaching hospitals in Malaysia. Eligible type 2 diabetes mellitus subjects will be randomly assigned to receive either acupuncture (n = 30) or a placebo (n = 30). The intervention is carried out using press needle or press placebo on abdomen area (10 sessions of treatment). Both groups will continue with their routine diabetes care. Primary outcome of HOMA-IR will be measured at the time of recruitment (-week 0), and after completion of 10 sessions (week 7) of the treatment. Additionally, secondary outcome of HRQoL will be measured at the time of recruitment (-week 0), after completion of 5 sessions (week 3/4), and 10 sessions (week 7) of the treatment. Any adverse event will be recorded at every visit. Discussion The findings of this study will provide important clinical evidence for the effect of acupuncture as adjunctive therapy on HOMA-IR, adiposity and HRQoL of type 2 diabetes mellitus. Trial registration number NCT04829045.

show abstract

“…According to the theory of traditional Chinese medicine (TCM), acupuncture can regulate qi and blood and have a direct impact on bioavailability of substances of the body [18]. In the past 20 years, several randomized controlled trials (RCTs) have been conducted on the effectiveness of acupuncture on DM and its complications [19][20][21]. It has been demonstrated that acupuncture may improve insulin sensitivity [18,22] and c-peptide levels through effective treatment against metabolic disturbances such as hyperglycemia [21,23,24], overweight [24,25], in ammation [26], while improving lipid metabolism [27].…”

mentioning

confidence: 99%

Effectiveness of Acupuncture as Adjunctive Therapy in Type 2 Diabetic: Study Protocol for a Randomized Controlled Trial

Cheok

Shariff

Chan

et al. 2022

Preprint

View full text Add to dashboard Cite

Background: The incidence of type 2 diabetes mellitus is increasing worldwide. The literature suggests that acupuncture is a possible complementary therapy for type 2 diabetes mellitus. This study aims to determine the effect of acupuncture as an adjunctive therapy on homeostasis model assessment-insulin resistance (HOMA-IR), adiposity and health-related quality of life (HRQOL) in patients with type 2 diabetes mellitus. Method and design: This randomised, double-blind, placebo controlled and parallel design trial will be carried out in three public university teaching hospitals in Malaysia. Eligible type 2 diabetes mellitus subjects will be randomly assigned to receive either acupuncture (n=30) or a placebo (n=30). The intervention is carried out using acupuncture ‘press’ needle on abdomen area (10 sessions of treatment), twice a week over 6 weeks. Both groups will continue with their routine diabetes care. Primary outcome of HOMA-IR and secondary outcomes of body mass index and waist circumference will be measured at the time of recruitment (baseline) and after completion of 10 sessions (week 7) of the treatment. Additionally, secondary outcome of HRQOL will be measured at the time of recruitment (baseline), after completion of 5 sessions (week 3/4) and 10 sessions (week 7) of the treatment. Any adverse event will be recorded at every visit.Discussion: The findings of this study will provide important clinical evidence for the effect of acupuncture as adjunctive therapy on HOMA-IR, adiposity and HRQOL of type 2 diabetes mellitus. Name of the registry: US National Institutes of Health Clinical Trials Registry (ClinicalTrials.gov). Trial registration Number: NCT04829045 Date of registration: 2 April 2021URL of trial registry record: https://clinicaltrials.gov/ct2/show/NCT04829045?cond=Type+2+diabetes%2C+acupuncture&draw=2&rank=1

show abstract

Study on the levels of calcitonin gene-related peptide, somatostatin and inflammatory factors in patients with coronary artery disease complicated with type 2 diabetes mellitus

Cited by 3 publications

References 0 publications

Progress Research into the Treatment of Newly Diagnosed Type 2 Diabetes with Traditional Chinese Medicine

Progress Research into the Treatment of Newly Diagnosed Type 2 Diabetes with Traditional Chinese Medicine

Effectiveness of acupuncture as adjunctive therapy in type 2 diabetic: Study protocol for a randomized controlled trial

Effectiveness of Acupuncture as Adjunctive Therapy in Type 2 Diabetic: Study Protocol for a Randomized Controlled Trial

Contact Info

Product

Resources

About